Remdesivir for Outpatient Management: Time to Wait, Not to Act

Am J Med. 2022 Mar;135(3):e80. doi: 10.1016/j.amjmed.2021.07.009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • COVID-19 Drug Treatment*
  • Humans
  • Outpatients*

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine